Addisu Kefyalew Dagnew, Hsu Wei-Hsin, Hailemeskel Balkew Zewge, Andrgie Abegaz Tizazu, Chou Hsiao-Ying, Yuh Chiou-Hwa, Lai Juin-Yih, Tsai Hsieh-Chih
Faculty of Chemical and Food Engineering, Institute of Technology, Bahir Dar University, Bahir Dar, Ethiopia P. O. Box 26.
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, 350 Miaoli, Taiwan.
ACS Biomater Sci Eng. 2019 Oct 14;5(10):5453-5469. doi: 10.1021/acsbiomaterials.9b01226. Epub 2019 Sep 20.
Integrating anticancer drugs and diagnostic agents in a polymer nanosystem is an emerging and promising strategy for improving cancer treatment. However, the development of multifunctional nanoparticles (NPs) for an "all-in-one" platform characterized by specific targeting, therapeutic efficiency, and imaging feedback remains an unmet clinical need. In this study, pH-responsive mixed-lanthanide-based multifunctional NPs were fabricated based on simple metal-ligand interactions for simultaneous cancer cell imaging and drug delivery. We investigated two new systems of alginate-polydopamine complexed with either terbium/europium or dysprosium/erbium oxide NPs (Tb/Eu@AlgPDA or Dy/Er@AlgPDA NPs). Tb/Eu@AlgPDA NPs were then functionalized with the tumor-targeting ligand folic acid (FA) and loaded with the anticancer drug doxorubicin (DOX) to form FA-Tb/Eu@AlgPDA-DOX NPs. Using such systems, the mussel-inspired property of PDA was introduced to improve tumor targetability and penetration, in addition to active targeting (via FA-folate receptor interactions). Determining the photoluminescence efficiency showed that the Tb/Eu@AlgPDA system was superior to the Dy/Er@AlgPDA system, presenting intense and sharp emission peaks on the fluorescence spectra. In addition, compared to Dy/Er@AlgPDA NPs (82.4%), Tb/Eu@AlgPDA NPs exhibited negligible cytotoxicity with >93.3% HeLa cell viability found in MTT assays at NP concentrations of up to 0.50 mg/mL and high biocompatibility when incubated with zebrafish () embryos and larvae. The FA-Tb/Eu@AlgPDA-DOX system exhibited a pH-responsive and sustained drug-release pattern. In a spheroid model of HeLa cells, the FA-Tb/Eu@AlgPDA-DOX system showed a better penetration efficiency and spheroid growth-inhibitory effect than free DOX. After incubation with zebrafish embryos, the FA-Tb/Eu@AlgPDA-DOX system also showed improved antitumor efficacies versus the other experimental groups in HeLa tumor cell xenografted zebrafish. Therefore, our results suggested that FA-Tb/Eu@AlgPDA-DOX NPs are promising multifunctional nanocarriers with therapeutic capacity for tumor targeting and penetration.
将抗癌药物和诊断剂整合到聚合物纳米系统中是一种新兴且有前景的改善癌症治疗的策略。然而,开发具有特异性靶向、治疗效果和成像反馈特征的“一体化”多功能纳米颗粒(NPs)仍然是尚未满足的临床需求。在本研究中,基于简单的金属 - 配体相互作用制备了pH响应性混合镧系多功能NPs,用于同时进行癌细胞成像和药物递送。我们研究了藻酸盐 - 聚多巴胺与铽/铕或镝/铒氧化物NPs(Tb/Eu@AlgPDA或Dy/Er@AlgPDA NPs)复合的两个新系统。然后用肿瘤靶向配体叶酸(FA)对Tb/Eu@AlgPDA NPs进行功能化,并负载抗癌药物阿霉素(DOX),形成FA-Tb/Eu@AlgPDA-DOX NPs。使用这样的系统,除了主动靶向(通过FA - 叶酸受体相互作用)之外,还引入了受贻贝启发的PDA特性以提高肿瘤靶向性和渗透性。光致发光效率的测定表明,Tb/Eu@AlgPDA系统优于Dy/Er@AlgPDA系统,在荧光光谱上呈现出强烈且尖锐的发射峰。此外,与Dy/Er@AlgPDA NPs(82.4%)相比,在NP浓度高达0.50 mg/mL的MTT试验中,Tb/Eu@AlgPDA NPs表现出可忽略不计的细胞毒性,HeLa细胞活力>93.3%,并且与斑马鱼胚胎和幼虫孵育时具有高生物相容性。FA-Tb/Eu@AlgPDA-DOX系统表现出pH响应性和持续的药物释放模式。在HeLa细胞的球体模型中,FA-Tb/Eu@AlgPDA-DOX系统显示出比游离DOX更好的渗透效率和球体生长抑制作用。与斑马鱼胚胎孵育后,FA-Tb/Eu@AlgPDA-DOX系统在HeLa肿瘤细胞异种移植斑马鱼中也显示出比其他实验组更好的抗肿瘤效果。因此,我们的结果表明,FA-Tb/Eu@AlgPDA-DOX NPs是有前景的多功能纳米载体,具有肿瘤靶向和渗透的治疗能力。